Alexion’s information blackout leaves investors in dark

The sudden resignations of a CEO and CFO in the middle of a probe of sales tactics is the sort of development that needs explanation. Alexion Pharmaceuticals Inc. investors got no such explanation Monday morning, when the company unexpectedly announced it had replaced its CEO and CFO. What they got instead was a brief, chipper,…

Want More Free?

To access 2 more articles, please log in or register for free.

Registered users get access to a limited number of free articles every month.

Register Now

Already registered? Login to access more free articles.

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -